An in vitro screening system for genitalia development

Active Grant Awarded

Award ID
R21ES038435
Recipient
Awarding agency
Obligated
$419,676

Award facts

Assistance listing
93.113 Environmental Health
Completion date 32% complete
Place of performance
University City, MO 63130, USA

Award details come from USAspending.gov.

About this award

The Department of Health and Human Services' National Institutes of Health, National Institute of Environmental Health Sciences, awarded The Washington University, through its Office of Sponsored Research Services division, $419,676 in grant funding on April 2, 2026, under Assistance Listing 93.113, Environmental Health. Ultimate completion is April 2, 2028, and performance is in University City, Missouri 63130.

The project develops an in vitro screening system for genitalia development to identify genetic regulators of urethral closure and genital masculinization, relevant to hypospadias. Building on 31 high-priority candidate transcription factors downstream of the androgen receptor that the team previously identified, the work uses two purified GT mesenchymal populations to add cellular and functional resolution to an established high-throughput screening system. Aim I isolates pure mesenchymal populations from the developing GT using two tissue-specific mouse Cre lines and tests their response to androgen stimulation. Aim II runs a proof-of-concept screen for transcription factors governing either proliferation or migration.

A sub-award dated August 25, 2026 (R21ES038435-WU-26-0608) passes the same project title and scope to University of Missouri System, doing business as University of Missouri, through its University of Missouri-St. Louis Office of Research.

Description

Abstract
Genital malformation including hypospadias represents the second most common male birth defect after cardiac defect. In the past 50 years, hypospadias incidence has doubled along with other male reproductive abnormalities. IT is suspected that fetal exposure to endocrine disruptors may have contributed to this increase. However, the etiology of hypospadias is still largely unclear. Both environmental and genetic factors are involved. Thus, there is an urgent need to understand genetic pathways regulating urethral closure as well as lower urinary tract development in general. Unfortunately, insufficient prospective screening tools have prevented the rapid identification of causative genes. We have recently developed a streamlined forward genetic screening technology combining in vivo and in vitro approaches to rapidly identify crucial regulators of genital masculinization and lower urinary tract development. As a result, we have identified 31 high priority candidate transcription factors downstream of androgen receptor, regulating genital masculinization. In light of recent discovery that an extra-genital cell population migrates into the developing genitalia and is required for urethral closure, this proposal will use two purified GT mesenchymal populations to increase the cellular and functional resolution of our established high-throughput screening system. We will use these novel screening systems to reevaluate the function of transcription factors during urethral closure. In aim I, we will use two tissue-specific mouse CRE lines to isolate pure populations of mesenchymal cells in the developing GT and test their cellular response to androgen stimulation. In aim II, we will perform a proof-of-concept screen for transcription factors governing either their proliferation or migration. Together, these studies should greatly accelerate the discovery progress for master regulators of urethral closure. Our long-term goal is to use mouse molecular genetics to understand the process of urethral closure and the etiology of genital malformations, such as hypospadias.

Subawards

Subrecipient Amount Awarded
University Of Missouri System Project Title: An in vitro screening system for genitalia development Project Context/ Background: Hypospadias is a congenital anomaly that is defined as an… $49,231

Quick answers

Who received award R21ES038435?

R21ES038435 was awarded to The Washington University by National Institute of Environmental Health Sciences (National Institutes of Health) on April 2, 2026.

How much is award R21ES038435 worth?

$419,676 has been obligated on R21ES038435.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award